People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Optofluidics, Inc. | — | Biotechnology | Series A | $19.4M | $96.7M | 2018 |
| Nevoa Life Sciences Holdings, Inc. | — | Other | Series A | $16.4M | $23.3M | 2018 |
ROBERT HART at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROBERT HART on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Hudson | 1 | 9 |
| William Snider | 1 | 7 |
| Joseph Keegan | 1 | 4 |
| Chad Souvignier | 1 | 4 |
| Shahram Hejazi | 1 | 3 |
| Joseph Damico | 1 | 3 |
| Casey McGlynn | 1 | 3 |
| Robert Wicke | 1 | 2 |
| Ernest Cunningham | 1 | 1 |
| Dan Bueschel | 1 | 1 |
| Daniel Bueschel | 1 | 1 |
| Timothy Barone | 1 | 1 |
| Allen Arroyo | 1 | 1 |
| Louis Laskis | 1 | 1 |
| Charles Risley | 1 | 1 |
| Rick Gordon | 1 | 1 |
| Bernardo Cordovez | 1 | 1 |
| Brad Edwards | 1 | 1 |
| Tim Barone | 1 | 1 |
| Mike Hudson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.